E
Emergent Biosolutions D
D
EBS
4.71000
USD
0.25
(5.61%)
مغلق
حجم التداول
31,067
الربح لكل سهم
0
العائد الربحي
-
P/E
-1
حجم السوق
255,927,392
الأخبار المقالات
العنوان: Emergent Biosolutions
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.